Bad Company: Microenvironmentally Mediated Resistance to Targeted Therapy in Melanoma

由 Almeida, Filipe V, Douglass, Stephen M., Fane, Mitchell E., Weeraratna, Ashani T.
發表在 Pigment Cell Melanoma Res (2018)

Genetic screening for single-cell variability modulators driving therapy resistance

由 Torre, Eduardo A., Arai, Eri, Bayatpour, Sareh, Jiang, Connie L., Beck, Lauren E., Emert, Benjamin L., Shaffer, Sydney M., Mellis, Ian A., Fane, Mitchell E., Alicea, Gretchen M., Budinich, Krista A., Weeraratna, Ashani T., Shi, Junwei, Raj, Arjun
發表在 Nat Genet (2021)

NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF

由 Fane, Mitchell E., Chhabra, Yash, Hollingsworth, David E.J., Simmons, Jacinta L., Spoerri, Loredana, Oh, Tae Gyu, Chauhan, Jagat, Chin, Toby, Harris, Lachlan, Harvey, Tracey J., Muscat, George E.O., Goding, Colin R., Sturm, Richard A, Haass, Nikolas K., Boyle, Glen M., Piper, Michael, Smith, Aaron G.
發表在 EBioMedicine (2017)

Changes in Aged Fibroblast Lipid Metabolism Induce Age-dependent Melanoma Cell Resistance to Targeted Therapy Via the Fatty Acid Transporter FATP2

由 Alicea, Gretchen M., Rebecca, Vito W., Goldman, Aaron R., Fane, Mitchell E., Douglass, Stephen M., Behera, Reeti, Webster, Marie R., Kugel, Curtis H., Ecker, Brett L., Caino, M. Cecilia, Kossenkov, Andrew V., Tang, Hsin-Yao, Frederick, Dennie T., Flaherty, Keith T., Xu, Xiaowei, Liu, Qin, Gabrilovich, Dmitry I., Herlyn, Meenhard, Blair, Ian A., Schug, Zachary T., Speicher, David W., Weeraratna, Ashani T.
發表在 Cancer Discov (2020)

Paradoxical role for wild type p53 in driving therapy resistance in melanoma

由 Webster, Marie R, Fane, Mitchell E, Alicea, Gretchen M, Basu, Subhasree, Kossenkov, Andrew V, Marino, Gloria E, Douglass, Stephen M, Kaur, Amanpreet, Ecker, Brett L, Gnanapradeepan, Keerthana, Ndoye, Abibatou, Kugel, Curtis, Valiga, Alexander, Palmer, Jessica, Liu, Qin, Xu, Xiaowei, Morris, Jessicamarie, Yin, Xiangfan, Wu, Hong, Xu, Wei, Zheng, Cathy, Karakousis, Giorgos C, Amaravadi, Ravi K, Mitchell, Tara C, Almeida, Filipe V, Xiao, Min, Rebecca, Vito W, Wang, Ying-Jie, Schuchter, Lynn M, Herlyn, Meenhard, Murphy, Maureen E, Weeraratna, Ashani T
發表在 Mol Cell (2019)

Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma

由 Webster, Marie R., Fane, Mitchell E., Alicea, Gretchen M., Basu, Subhasree, Kossenkov, Andrew V., Marino, Gloria E., Douglass, Stephen M., Kaur, Amanpreet, Ecker, Brett L., Gnanapradeepan, Keerthana, Ndoye, Abibatou, Kugel, Curtis, Valiga, Alexander, Palmer, Jessica, Liu, Qin, Xu, Xiaowei, Morris, Jessicamarie, Yin, Xiangfan, Wu, Hong, Xu, Wei, Zheng, Cathy, Karakousis, Giorgos C., Amaravadi, Ravi K., Mitchell, Tara C., Almeida, Filipe V., Xiao, Min, Rebecca, Vito W., Wang, Ying-Jie, Schuchter, Lynn M., Herlyn, Meenhard, Murphy, Maureen E., Weeraratna, Ashani T.
發表在 Mol Cell (2020)